APOE and Alzheimer disease: A patient is estimated to spend 5.38 (95% CI: 0.002–6.03) years with MCI, and 7.61 (95% CI: 0.002–8.88) years with AD after adjusting for demographics, APOE genotype, comorbidities, and medication use.